Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,358.00    0.00 (0.00%)
Bid:
2,300.00
Ask:
2,698.00
Spread: 398.00 (17.304%)
Market Cap: £28.44b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Statement re CMA Final Determinations

28 Oct 2021 07:03

RNS Number : 4990Q
SSE PLC
28 October 2021
 

SSE plc

CMA Final Determinations

28 October 2021

 

The CMA has today published a summary of its final determinations into SSEN Transmission's appeal against certain elements of Ofgem's RIIO-T2 price control settlement. The full final determinations and associated documents are expected to be provided to appellants and interveners later this week and then published by the CMA shortly thereafter.

SSEN Transmission welcomes that the CMA has upheld its appeals against the assumed 'Outperformance Wedge', and for changes to the Licence Modification Process.

However, SSEN Transmission is disappointed that the CMA has not upheld its appeals on the flawed Cost of Equity, or on changes to how Transmission Network Use of System Charges are recovered and the associated risk of under recovery this presents.

SSEN Transmission will continue to assess the full details of the CMA's final determinations as they become available and remains committed to work constructively with Ofgem and wider stakeholders as it continues to take forward ambitious plans to deliver a network for net zero.

ENQUIRIES:

Investors and Analysts ir@sse.com +44(0)345 0760 530

Media media@sse.com +44(0)345 0760 530

NOTES TO EDITORS:

SSEN Transmission, operating under licence held by Scottish Hydro Electric (SHE) Transmission plc, owns, operates and develops the high voltage electricity transmission system in the north of Scotland and remote islands.

SSEN Transmission is a wholly owned subsidiary of SSE plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFEAIFLDFIL
Date   Source Headline
9th Jun 20264:34 pmRNSDirector/PDMR Shareholding
9th Jun 20263:47 pmRNSNotification of Admission to Trading
5th Jun 202612:39 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:44 pmRNSIssue of Hybrid Capital Securities
1st Jun 202612:30 pmRNSAdmission to Trading
1st Jun 202612:21 pmRNSTotal Voting Rights
28th May 20267:00 amRNSPreliminary Results
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20268:43 amRNSTotal Voting Rights
29th Apr 20264:38 pmRNSHolding(s) in Company
22nd Apr 20268:42 amRNSHolding(s) in Company
9th Apr 20264:45 pmRNSDirector/PDMR Shareholding
7th Apr 20262:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:01 amEQSSSE PLC: Trading Update
1st Apr 20267:01 amEQSTotal Voting Rights
20th Mar 20262:57 pmRNSAdmission of Further Securities to Trading
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amEQSTotal Voting Rights
2nd Mar 20267:00 amRNSSSENT accepts Ofgem’s RIIO-T3 Final Determination
24th Feb 20267:00 amRNSNotice of Redemption
12th Feb 20264:05 pmRNSDirector/PDMR Shareholding
11th Feb 20263:15 pmRNSHolding(s) in Company
10th Feb 20264:44 pmRNSDirector/PDMR Shareholding
4th Feb 202611:46 amRNSDirector/PDMR Shareholding
4th Feb 20267:00 amRNSQ3 Trading Statement
2nd Feb 20267:00 amEQSSSE PLC: Total Voting Rights
30th Jan 20262:52 pmRNSDirector/PDMR Shareholding
29th Jan 202612:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:15 pmRNSAdditional Admission Application
14th Jan 20267:25 amRNSSSE secures 1.4GW CfD for Berwick Bank Wind Farm
8th Jan 20263:28 pmRNSScrip Alternative
8th Jan 20262:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
11th Dec 202511:40 amRNSScrip Dividend Scheme
10th Dec 20252:35 pmRNSHolding(s) in Company
10th Dec 20252:06 pmRNS2025 Sustainability Financing Framework
9th Dec 20253:50 pmRNSHolding(s) in Company
9th Dec 20253:48 pmRNSHolding(s) in Company
9th Dec 20251:52 pmRNSHolding(s) in Company
9th Dec 20251:41 pmRNSDirector/PDMR Shareholding
8th Dec 20251:14 pmRNSDirector/PDMR Shareholding
4th Dec 202511:44 amRNSHolding(s) in Company
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.